01/04/2019 11:00:00

New CEO Leads Terumo BCT’s Ambition to Shape the Future of Blood and Cell Technologies in Healthcare

LAKEWOOD, Colo., April 01, 2019 (GLOBE NEWSWIRE) -- Antoinette Gawin is expanding Terumo BCT, a biomedical company, beyond its heritage in working with blood centers and hospitals to serve rapidly growing areas of healthcare, such as cell therapy technologies and regenerative medicine. Terumo BCT produces technologies that collect and process blood and cells used in a wide range of therapeutic areas. As President and Chief Executive Officer, Gawin will oversee the company with nearly $1 billion in revenue and 7,000 associates supporting customers in 130 countries.

“Terumo BCT has been passionately engaged in enabling access to blood and cells around the world. Our innovations automate complex processes and help researchers and clinicians unlock the healing potential of an individual’s genetic material,” Gawin said. “We must diversify our portfolio to fund continued innovation in this cost-conscious healthcare environment and remain relevant to our customers.” 

Strategies include embedding the company’s products in the cell therapy manufacturing process, increasing the awareness of therapeutic apheresis as a treatment to address autoimmune diseases, building infrastructure in growth geographies and expanding beyond devices into patient data management and services. These efforts increase Terumo BCT’s ability to influence healthcare standards and reach more patients.

Gawin succeeds David Perez, who has led the company for 20 years and will continue until June 2019 on the board of directors for Terumo Corporation, parent company of Terumo BCT. Gawin is now one of three women serving the Terumo Corporation as executive officers. This progressive Tokyo-based company has been contributing to society through healthcare for nearly 100 years.

Diverse Perspectives

Gawin values all aspects of diversity and believes diversity is a foundation for patient-centered innovation. These values are reflected in her passionate commitment to patients and drive her interest in changing policy and practices to increase access to healthcare technologies. Gawin has brought experience in public policy and her perspective as a global citizen to nonprofit organizations that promote equitable access to healthcare, education and clean water. 

Gawin

joined Terumo BCT in 2016 in the role of executive vice president, global commercial, bringing nearly 30 years’ experience directing diverse global teams and transformational change across Baxter and GE, with global leadership roles at GE Healthcare Technologies, GE Industrial and Power Systems, GE Information Services and GE Financial Services. She holds a master’s degree in health policy from DePaul University and bachelor’s degrees in economics and English from the University of Michigan.

About Terumo BCT

Terumo BCT, a global leader in blood component, therapeutic apheresis and cell therapy technologies, is the only company with the unique combination of apheresis collections, manual and automated whole blood processing and pathogen reduction technologies. We believe in the potential of blood and cells to do even more for patients than they do today. This belief inspires our innovation and strengthens our collaboration with customers. www.terumobct.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/916aa8a7-3fa5-41d9-a167-dce1ab4cb245

Media Contact

Terumo BCT

Christine Romero

Corporate Communications            

+1.303.205.2599

press@terumobct.com

Terumo BCT.jpg

Del

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
11 Jul
 
Kan vi tåle en fredagsjoke? (og det er ikke Fingerprint Cards jeg tænker på :-) ) En blind mand går ..
31
11 Jul
VELO
Lånt fra skribent i FB gruppen “Veloxis Investor” “Hovedorganisationen for transplantationer i US..
26
12 Jul
 
Man hører det igen og igen. Donald Trump er ubegavet, dum, idiot - derudover racist, nazist - en opp..
25
10 Jul
GEN
I kurs 1500 var der også taget meget forskud på glæderne - og så har der været et par setbacks tilli..
18
12 Jul
PNDORA
Har lige været i Frankrig hvor jeg kiggede forbi en butik hvor jeg konstaterede at der var godt med ..
16
11 Jul
DANSKE
Helt enig - desværre.   Danske Bank har i den grad været åben og informativ inden for rammerne af hv..
16
12 Jul
 
Han er den største psykopat, der nogen sinde har siddet ved magten, og han er DYBT ustabil og højst ..
15
15 Jul
BAVA
Tænk engang, med alt det du skriver om Bavarian og ebola vaccinen, så skulle man tro, at du bare ved..
12
12 Jul
BAVA
Dejligt at se den er begyndt at stige - indenfor 2 1/2 mdr kommer der til at ske rigtig meget:   Ko..
12
12 Jul
 
Det eneste konkrete Tumpen har budt på er en ufinansieret skattereform. Det billigste trick i verden..
12

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
ROSEN, A TOP RANKED LAW FIRM, Reminds RCI Hospitality Holdings, Inc. Investors of July 22nd Deadline in Securities Class Action – RICK
2
SolarWinds New APAC Research Shows Insider Threats Rank as Top Cybersecurity Threat Concern
3
ROSEN, A TOP RANKED LAW FIRM, Reminds Community Health Systems, Inc. Investors of Important July 29th Deadline in the Securities Class Action– CYH
4
Black Creek Group Industrial Real Estate Investment Platform to be acquired by Prologis for $3.99 Billion
5
Hagens Berman Reminds MicroStrategy (MSTR) Investors of the Firm’s Investigation of Possible Disclosure Violations

Latest news


Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
17 July 2019 00:17:45
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190703.1 - EUROWEB5 - 2019-07-17 01:17:45 - 2019-07-17 00:17:45 - 1000 - Website: OKAY